Edward M. Hurwitz's most recent trade in Dyne Therapeutics Inc was a trade of 35,000 Stock option (right to buy) done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 35,000 | 35,000 | - | - | Stock option (right to buy) | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 22,000 | 22,000 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 6,500 | 0 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 6,500 | 44,074 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 3,750 | 3,750 | - | - | Restricted Stock Unit | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 6,500 | 6,500 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,500 | 37,574 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,500 | 0 | - | - | Restricted Stock Unit | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 13,980,992 | 0 | - | - | Series A Preferred Stock | ||
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 4,893,347 | 13,980,992 | - | - | Series A Preferred Stock | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 4,614,943 | 4,614,943 | - | - | Common Stock | ||
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 1,326,313 | 1,326,313 | - | - | Series B Preferred Stock | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 1,326,313 | 0 | - | - | Series B Preferred Stock | ||
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 743,076 | 0 | - | - | Series A Preferred Stock | ||
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 275,932 | 0 | - | - | Series A Preferred Stock | ||
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 260,077 | 743,076 | - | - | Series A Preferred Stock | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 245,279 | 245,279 | - | - | Common Stock | ||
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 96,576 | 275,932 | - | - | Series A Preferred Stock | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 91,081 | 91,081 | - | - | Common Stock | ||
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 70,492 | 70,492 | - | - | Series B Preferred Stock | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 70,492 | 0 | - | - | Series B Preferred Stock | ||
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 26,176 | 26,176 | - | - | Series B Preferred Stock | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 26,176 | 0 | - | - | Series B Preferred Stock |